TD 17.04 (NEURONE)

Primary sponsor: Trans Tasman Radiation Oncology Group (TROG)

Title

Intracranial stereotactic radiosurgery with or without memantine

The aim of the study is to determine if the addition of memantine will reduce the cognitive decline in patients treated with SRS

Approximately Quarter 2, 2018

Dr Eric Hau, Crown Princess Mary Cancer Centre, Westmead

Rebecca Montgomery
Clinical Trials Project Manager
TROG Trial Coordinating Centre
Phone: +61 2 4014 3910
Email: rebecca.montgomery@trog.com.au

We are thankful to our 14,500 patients who have participated in our research. Please continue the generous support.

Tweets by @TROGfightcancer